Impact on Consumer Behavior in the Americas: COVID-19 Survey Snapshot - Week 6
Summary The analyst is carrying out weekly consumer surveys in 11 countries between 25th March and 31st May 2020, to track consumer sentiment and shopping behavior during the Coronavirus (COVID19) pandemic.The sample size is 500 respondents per country, per week.
The two countries in scope for the Americas are Brazil and the USA.Questions are consistent every week, and cover consumer opinions about COVID-19, buying behavior and product choices and impact of the Coronavirus (COVID19) outbreak on consumers’ lifestyle and activities.
This report summarizes the key findings from responses in week 6.
Key Highlights - Both Americans’ and Brazilians’ concern about COVID-19 developed at a similar rate. However, week six has seen these attitudes begin to change. More than half of Brazilians (57%) are extremely concerned about the global COVID-19 outbreak, this is the same number that were concerned in week 5 showing concern has maintained at the same level over the past week. However, concern in the US has dropped significantly by 6%, highlighting that tensions around COVID-19 are beginning to ease.
- In the US, 69% of millennials have had their holidays cancelled or suspended, whilst only 32% of baby boomers have experienced the same. The US has significant travel restrictions in place with a number of full bans in effect. This suggests that a lot more millennials are traveling abroad from the US, as opposed to their baby boomer counterparts.
- There has been a significant drop off in footfall to fast food and casual restaurants in both Brazil and the US. In Brazil, 61% of respondents have stopped going to casual restaurants, whilst in the US 35% have stopped going. The difference in people attending casual restaurants may highlight the difference in attitudes surrounding public environments between the countries.
Scope - This report provides an insight into how the coronavirus pandemic is shaping consumer sentiment in Brazil and the USA.
- It summarizes key findings from the survey ‘s responses and offers insight into how destinations and industry players can adapt to meet changing demands and needs.
Reasons to Buy - Gain access to primary survey data results.
- Understand how the coronavirus pandemic is changing consumer attitudes.
- Assess how you can adapt your business plans and strategies to better meet these changing needs.
Our reports have been used by over 10K customers, including:
The human microbiome market is expected to reach US$ 2,921.68 million by 2028 from US$ 718.95 million in 2021; it is estimated to grow at a CAGR of 22.2% during 2021-2028. The market growth is mainly attributed to factors such as the increasing incidence of lifestyle diseases, rising focus on human microbiome therapies, and growing...
Best foot forward: Revenue will likely rise as more healthcare providers stress the importance of preventive care Abstract Podiatrists in the US Over the five years to 2019, the Podiatrists industry has stepped in the right direction. Revenue growth has been supported by the aging US population and...
Stretch goals: Rising disposable incomes and an aging population will drive revenue growth Abstract Physical Therapists in the US Over the five years to 2019, the role of physical therapy in promoting health and wellness has increased, benefiting this industry. As the number of individuals aged 50 and...
Strong arch: As the unemployment rate declines, the industry’s customer base will grow Abstract Eyebrow Services in the USOperators in this industry are primarily engaged in threading, waxing or otherwise servicing eyebrows. Hair and nail salons are not included in this industry. This report covers...
The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period. The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R&D spending & healthcare expenditure. Emerging markets are expected...
The global organoids market is expected to reach US$ 3,420.40 million by 2027 from US$ 689.47 million in 2019. The market is estimated to grow at a CAGR of 22.1% from 2020 to 2027. Increasing demand for tumor modelling and biobanking, rising adoption of personalized drugs, and growing focus on developing alternatives for animal testing...
Healthy future: Despite the mounting likelihood of new regulation, industry revenue will likely grow Abstract Cryogenic Biobanking Services Since the landmark scientific achievement of human genome sequencing in 2003, the Cryogenic Biobanking Services industry is increasingly viewed as the link between...
The global human microbiome market is expected to reach US$ 1,873.53 million by 2027 from US$ 356.29 million in 2019. The market is estimated to grow with a CAGR of 23.6% from 2020 to 2027. The growth of the market is driven by the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies,...
Increasing emphasis on early disease detection and prevention is expected to drive the growth of the global carrier screening market. The global carrier screening market size is expected to grow from USD 1.8 billion in 2019 to USD 4.0 billion by 2024, at a CAGR of 17.5% during the forecast period. Growth in the carrier...
Gross Domestic Expenditure On R&D
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.